You are here

Home » CERID Bibliography

CERID Bibliography

Export 105 results:
Author Title Type [ Year(Asc)]
Filters: Author is Liles, W Conrad  [Clear All Filters]
2013
Page AV, W Liles C. Biomarkers of endothelial activation/dysfunction in infectious diseases. Virulence. 2013 ;4(6):507-16.
Graham SM, Mwilu R, W Liles C. Clinical utility of biomarkers of endothelial activation and coagulation for prognosis in HIV infection: A systematic review. Virulence. 2013 ;4(6):564-71.
Weiss DJ, Bates JHt, Gilbert T, W Liles C, Lutzko C, Rajagopal J, Prockop DJ. Conference Report: Stem Cells and Cell Therapies in Lung Biology and Diseases University of Vermont, July 2011. Ann Am Thorac Soc. 2013 .
Jacob ST, Pavlinac PB, Nakiyingi L, Banura P, Baeten JM, Morgan K, Magaret A, Manabe Y, Reynolds SJ, W Liles C, et al. Correction: Mycobacterium tuberculosis Bacteremia in a Cohort of HIV-Infected Patients Hospitalized with Severe Sepsis in Uganda-High Frequency, Low Clinical Suspicion and Derivation of a Clinical Prediction Score. PLoS One. 2013 ;8(8).
Page AV, Tarr PI, Watkins SL, Rajwans N, Petruzziello-Pellegrini TN, Marsden PA, Kain KC, W Liles C. Dysregulation of Angiopoietin 1 and 2 in Escherichia coli O157:H7 Infection and the Hemolytic-Uremic Syndrome. J Infect Dis. 2013 ;208(6):929-33.
Darwish I, W Liles C. Emerging therapeutic strategies to prevent infection-related microvascular endothelial activation and dysfunction. Virulence. 2013 ;4(6):572-82.
Graham SM, Rajwans N, Jaoko W, Estambale BBA, R McClelland S, Overbaugh J, W Liles C. Endothelial activation biomarkers increase after HIV-1 acquisition: plasma vascular cell adhesion molecule-1 predicts disease progression. AIDS. 2013 ;27(11):1803-13.
Page AV, W Liles C. Enterohemorrhagic Escherichia coli Infections and the Hemolytic-Uremic Syndrome. Med Clin North Am. 2013 ;97(4):681-95, xi.
Darwish I, Banner D, Mubareka S, Kim H, Besla R, Kelvin DJ, Kain KC, W Liles C. Mesenchymal stromal (stem) cell therapy fails to improve outcomes in experimental severe influenza. PLoS One. 2013 ;8(8):e71761.
Jacob ST, Pavlinac PB, Nakiyingi L, Banura P, Baeten JM, Morgan K, Magaret A, Manabe Y, Reynolds SJ, W Liles C, et al. Mycobacterium tuberculosis Bacteremia in a Cohort of HIV-Infected Patients Hospitalized with Severe Sepsis in Uganda-High Frequency, Low Clinical Sand Derivation of a Clinical Prediction Score. PLoS One. 2013 ;8(8):e70305.
Graham SM, Rajwans N, Tapia KA, Jaoko W, Estambale BBa, R McClelland S, Overbaugh J, W Liles C. A prospective study of endothelial activation biomarkers, including plasma angiopoietin-1 and angiopoietin-2, in Kenyan women initiating antiretroviral therapy. BMC Infect Dis. 2013 ;13(1):263.
W Liles C. Special focus: Endothelial activation/dysfunction. Virulence. 2013 ;4(6):504-6.
Higgins SJ, Xing K, Kim H, Kain DC, Wang F, Dhabangi A, Musoke C, Cserti-Gazdewich CM, Tracey KJ, Kain KC, et al. Systemic release of high mobility group box 1 (HMGB1) protein is associated with severe and fatal Plasmodium falciparum malaria. Malar J. 2013 ;12:105.
Salit IE, W Liles C, Smith C. Tularemia endocarditis from domestic pet exposure. Am J Med. 2013 ;126(10):e1.
2012
Wolofsky KT, Ayi K, Branch DR, Hult AK, Olsson ML, W Liles C, Cserti-Gazdewich CM, Kain KC. ABO blood groups influence macrophage-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes. PLoS Pathog. 2012 ;8(10):e1002942.
W Liles C. Is angiopoietin-2 the key piece in the sepsis puzzle?*. Crit Care Med. 2012 ;40(11):3100-1.
Xing K, Murthy S, W Liles C, Singh JM. Clinical utility of biomarkers of endothelial activation in sepsis--a systematic review. Crit Care. 2012 ;16(1):R7.
Petruzziello-Pellegrini TN, Yuen DA, Page AV, Patel S, Soltyk AM, Matouk CC, Wong DK, Turgeon PJ, Fish JE, Ho JJDavid, et al. The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice. J Clin Invest. 2012 ;122(2):759-76.
MacMullin G, Mackenzie R, Lau R, Khang J, Zhang H, Rajwans N, W Liles C, Pillai DR. Host immune response in returning travellers infected with malaria. Malar J. 2012 ;11:148.
Darwish I, Miller C, Kain KC, W Liles C. Inhaled nitric oxide therapy fails to improve outcome in experimental severe influenza. Int J Med Sci. 2012 ;9(2):157-62.
Santos CC dos, Murthy S, Hu P, Shan Y, Haitsma JJ, Mei SHJ, Stewart DJ, W Liles C. Network analysis of transcriptional responses induced by mesenchymal stem cell treatment of experimental sepsis. Am J Pathol. 2012 ;181(5):1681-92.
2011
Ricciuto DR, Santos CC dos, Hawkes M, Toltl LJ, Conroy AL, Rajwans N, Lafferty EI, Cook DJ, Fox-Robichaud A, Kahnamoui K, et al. Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med. 2011 ;39(4):702-10.
Page AV, W Liles C. Colony-stimulating factors in the prevention and management of infectious diseases. Infect Dis Clin North Am. 2011 ;25(4):803-17.
Erdman LK, Dhabangi A, Musoke C, Conroy AL, Hawkes M, Higgins S, Rajwans N, Wolofsky KT, Streiner DL, W Liles C, et al. Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study. PLoS One. 2011 ;6(2):e17440.
Conroy AL, McDonald CR, Silver KL, W Liles C, Kain KC. Complement activation: a critical mediator of adverse fetal outcomes in placental malaria?. Trends Parasitol. 2011 ;27(7):294-9.

Pages